Advertisements

Aytu Bioscience Inc (AYTU) Stock Quote

Detailed Quote for Aytu BioScience Inc. (AYTU)
$ 0.326   -0.0058 (-1.75%) Volume: 224.15k 9:55 AM EDT 19-Jun-2018
Today 5d 1m 3m 1y more
Last Price
0.326
Change $
0.0058
Change %
1.75%
Tick
N/A
Bid
0.326
Bid Size
11,100
Ask
0.33
Ask Size
100
Open
0.3102
High
0.33
Low
0.3102
Prev Close
0.3318
Last Trade
9:55
Volume
224.15k
52 Wk Hi
6.82000017
52 Wk Low
0.289999991
Market Cap
11.7m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
35,883,069
EPS (TTM)
-9.52000045
PE Ratio
N/A
Exchange
NCM
News and Media for Aytu BioScience Inc. (AYTU)
Sector News | Topic News
News for Aytu BioScience Inc. (AYTU)
Wed, Jun 13, 2018
8:05 AM Aytu BioScience Enters $1.8 Billion U.S. Prescription Sleep Aid Market with Exclusive License to Zolpimist(TM) to Expand Company's Commercial-Stage Product Portfolio - ACCESSWIRE
Thu, May 24, 2018
7:20 AM Wired News - Acceleron Pharma Commences PULSAR Phase-2 Trial of Sotatercept in Pulmonary Arterial Hypertension - ACCESSWIRE IA
Wed, May 23, 2018
8:05 AM Aytu BioScience, Inc. to Present at the 8th Annual LD Micro Invitational Investor Conference - ACCESSWIRE
Mon, May 14, 2018
5:09 PM AYTU BIOSCIENCE beats by $0.76, misses on revenue - SeekingAlpha
4:01 PM Aytu BioScience Provides Fiscal Third Quarter 2018 Business Update - Live Conference Call and Webcast Today at 4:30 pm ET - ACCESSWIRE
Tue, May 08, 2018
8:05 AM Aytu BioScience CEO Issues Letter to Shareholders - ACCESSWIRE
Mon, May 07, 2018
8:05 AM Aytu BioScience to Report Fiscal Third Quarter 2018 Results and Business Update - ACCESSWIRE
Thu, May 03, 2018
8:30 AM Aytu BioScience Featured in Local ABC News Segment (VIDEO): "UM Doctors Test New Medication for Treating Men with Low Testosterone; Nasal Testosterone Gel doesn't Appear to have Negative Side Effects, Doctors Say." - ACCESSWIRE
Tue, Apr 03, 2018
9:05 AM Aytu BioScience to Present at The MicroCap Conference on April 10th in New York City at the Essex House - ACCESSWIRE
Wed, Mar 28, 2018
9:05 AM Aytu BioScience Announces Exercise of Underwriters' Over-Allotment Option - ACCESSWIRE
Tue, Mar 20, 2018
8:05 AM Aytu BioScience Presents New Research Findings for Natesto(R) at the Endocrine Society's 100th Annual Meeting - ACCESSWIRE
Wed, Mar 07, 2018
8:05 AM Aytu BioScience Receives Market Registration for the MiOXSYS\u00AE System for Male Infertility in Mexico - PR Newswire
Tue, Mar 06, 2018
1:19 PM Aytu BioScience Announces Closing of $12,000,000 Public Offering - PR Newswire
1:14 PM Zynex Appoints New Independent Board Member - PR Newswire
Fri, Mar 02, 2018
11:35 AM Tauriga Sciences Inc. Acquires Equity Stake in Colorado based NASDAQ Listed Biotechnology Firm Focused in the Medical Field of Urology - GlobeNewswire
7:17 AM Aytu Bio prices equity offering; shares down 24% premarket - SeekingAlpha
Thu, Mar 01, 2018
7:30 PM Aytu BioScience Announces Pricing of $12,000,000 Public Offering - PR Newswire
Thu, Feb 22, 2018
3:14 PM Ampio Pharmaceuticals: Overhyped And Undercapitalized - SeekingAlpha
Wed, Feb 21, 2018
8:05 AM Aytu BioScience Provides Update on the Continued Growth of Natesto\u00AE in the U.S. - PR Newswire
Thu, Feb 08, 2018
4:44 PM AYTU BIOSCIENCE reports Q2 results - SeekingAlpha
More News for AYTU >>

Tags for Aytu Bioscience Inc

Research stocks or mutual funds related to Aytu Bioscience Inc by keywords or tags. Find companies that have a similar focus to AYTU. The keywords below have been associated to AYTU by either user submission or electronic means.